A randomized, double-blind, placebo-controlled, dose escalation study of multiple oral dose administration of BIIB014 [V-2006] in subjects with early Parkinson's disease.

Trial Profile

A randomized, double-blind, placebo-controlled, dose escalation study of multiple oral dose administration of BIIB014 [V-2006] in subjects with early Parkinson's disease.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 03 Jun 2015

At a glance

  • Drugs Vipadenant (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions
  • Sponsors Biogen
  • Most Recent Events

    • 25 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top